Although many data indicate that the management of hypertension has improved over the last two decades, there is still a large proportion of hypertensive individuals who do not receive adequate ...

It's important to tell your doctor or pharmacist what medicines you are already taking, including those bought without a prescription and herbal medicines, before you start treatment with indapamide.

Essential hypertension is a chronic disease, which usually requires life-long treatment. One of the most important problems in the treatment of such a generally asymptomatic condition, such as ...

Hypertension can cause heart, brain, kidney and artery damage, increasing the incidence of cardiovascular disease and death. The purpose of antihypertensive treatment is not only lowering the blood ...

Widaplik is a single tablet, triple combination therapy for hypertension that is expected to be available in the fourth quarter of 2025. The Food and Drug Administration (FDA) has approved Widaplik ™ ...

Novel, single pill, triple combination with a standard dose and two lower doses that can deliver the efficacy benefits of combination therapy, with an established safety profile and good tolerability ...

George Medicines signs exclusive licensing agreement with Azurity Pharmaceuticals to commercialize WIDAPLIK™ (telmisartan, amlodipine and indapamide) tablets in the US An innovative single pill ...

* ANI Pharmaceuticals -launch of Indapamide tablets, 1.25mg and 2.5mg, used in treatment of hypertension & swelling associated with congestive heart failure Source text for Eikon: Further company ...

Clin Drug Invest. 2007;27(6):367-380. Fogari et al. [46] investigated the antihypertensive effects of four possible dose combinations of delapril 15 or 30mg and indapamide 1.25 or 2.5mg. They found ...